GGrantIndex
Sort

8,912 grants matching sars cov 2

CoVPN 5001 A prospective study of acute immune responses to SARS-CoV-2 infection SDMC

$673,501
Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · AI

Inhalation Therapy Platform for Coronavirus Infection Treatment

$673,364
Patrick S. Stayton · University Of Washington · R01 · FY2025 · AI

PROJECT 1: IMMUNE MEMORY

$673,340
Rafi Ahmed · Emory University · U19 · FY2024 · AI

Antibody repertoire characterization in the context of coronaviruses

$673,335
Ivelin Georgiev · Vanderbilt University Medical Center · R01 · FY2021 · AI

Improved scalability, sensitivity, and interpretability of pathogen detection, including SARS-CoV-2, in wastewater using high-throughput, highly multiplexed digital array PCR technology

$673,305
Rachel Todd Noble · Univ Of North Carolina Chapel Hill · U01 · FY2022 · DA

AMPK Regulation of ACE2 in Endothelial Health and Disease

$673,114
John Y-J Shyy · University Of California, San Diego · R01 · FY2023 · HL

SARS-CoV2 Sequencing Surveillance Program for Upstate South Carolina

$672,958
Hai Yao · Clemson University · P20 · FY2022 · GM

Early detection, containment, and management of COVID-19 in dialysis facilities using multi-modal data sources

$672,811
Yuedong Wang · University Of California Santa Barbara · R01 · FY2022 · DK

Viral Noncoding RNAs and Cell Transformation

$672,801
Joan A. Steitz · Yale University · R01 · FY2023 · CA

PROJECT 2: Determine clinically relevant host-viral dependency networks for respiratory infections including SARS-CoV-2

$672,529
Melanie Maria Ott · University Of California, San Francisco · U19 · FY2023 · AI

Development of an Oral Pan-Coronavirus Drug Cocktail

$672,447
Stephen J. Polyak · University Of Washington · R01 · FY2025 · AI

Characterizing Persistent Subclinical Neurobehavioral Effects of COVID-19 in a Diverse Urban Population

$672,352
Johanna Patricia Daily · Albert Einstein College Of Medicine · R01 · FY2024 · NS

Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1

$672,175
Priyamvada Acharya · Duke University · R01 · FY2024 · AI

Determinants of Coronavirus Fidelity in Replication and Pathogenesis

$672,084
Mark R Denison · Vanderbilt University Medical Center · R01 · FY2019 · AI

Determinants of Coronavirus Fidelity in Replication and Pathogenesis

$672,084
Mark R Denison · Vanderbilt University Medical Center · R01 · FY2022 · AI

Determinants of Coronavirus Fidelity in Replication and Pathogenesis

$672,084
Mark R Denison · Vanderbilt University Medical Center · R01 · FY2021 · AI

Determinants of Coronavirus Fidelity in Replication and Pathogenesis

$672,084
Mark R Denison · Vanderbilt University Medical Center · R01 · FY2020 · AI

Role of respiratory viral infections and inflammation in promoting metastatic outgrowth in the lung

$672,011
James V Degregori · University Of Colorado Denver · R01 · FY2025 · CA

The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence

$671,674
Veerle Bergink · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · MH

De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics

$671,529
David Baker · University Of Washington · R01 · FY2025 · AI

Porous silicon microparticle-based subunit vaccines for SARS-CoV-2

$671,187
Tian Wang · University Of Texas Med Br Galveston · R01 · FY2024 · AI

Immunologic basis of cardiac disease after severe COVID-19

$671,068
Chetan N Shenoy · University Of Minnesota · R01 · FY2024 · HL

Strengthening the Dementia Care Workforce: Analyzing Economic Policies' influence on Workers and their Patients Living with Dementia

$671,042
Norma B Coe · University Of Pennsylvania · R01 · FY2024 · AG

Nosocomial pneumonia impairs the cerebrovasculature

$671,024
Amy R Nelson · University Of South Florida · R01 · FY2025 · NS

SARS-CoV-2 in Correctional Populations: A collaborative, ethical approach to application of wastewater-based surveillance

$671,016
Anne C Spaulding · Emory University · U01 · FY2022 · DA